Biosensors Market

Chapter Outlines

Chapter 2 is an executive summary of the key insights captured in our report. It offers a high-level view of the current state of biosensors in drug discovery market and its likely evolution in the short term, mid-term and long term.

Chapter 3 provides a general overview of biosensors and its different components, including analyte, bioreceptor, transducer, electronics and display. Additionally, it highlights different types of biosensors, along with their applications in drug discovery. Further, the chapter includes information on the challenges associated with use of biosensors in this domain. 

Chapter 4 provides a detailed review of the current market landscape of biosensors in drug discovery, featuring information on the type of biosensor (optical biosensors, electrochemical biosensors, quartz crystal microbalance biosensors, thermal biosensors and magneto-electric biosensors), bioreceptor used (cells, proteins, lipids, enzymes, antibodies and undisclosed), drug discovery step(s) supported (disease modelling, target identification / validation, lead identification, lead optimization, and drug discovery (unspecified)), other applications (ADME assays, toxicity assays, cytotoxicity assays, cell analysis, drug characterization / validation assays and other assays), type of analyte analyzed (small molecules, cell / tissues, protein / peptides, antibodies, nucleotides, viruses, blood products, enzymes, biologics (unspecified) and others), type of carrier plate format (microplate-based sensor, flow through the sensor, chip-based static array sensor, polymerase chain reaction (PCR) format plates-based sensor and undisclosed), sample capacity (less than 96, 96 to 384, 385 to 1536, more than 1,536 and undisclosed), sample volume (1 to 50µl, 51 to 100 µl, 101 to 200 µl, more than 200 µl and undisclosed), type of detection (label-free and real-time) and type of systems (automatic, semi-automatic and undisclosed). In addition, the chapter features analysis related to biosensor developers based on multiple parameters, such as their year of establishment, company size, location of headquarters and leading players (in terms of number of biosensors developed). 

Chapter 5 presents a detailed product competitiveness analysis of biosensors in drug discovery, based on various relevant parameters, namely supplier power (based on the experience of the developer) and product competitiveness (based on various parameters, including type of biosensor, bioreceptor used, drug discovery step(s) supported, other application(s), type of analyte(s) analyzed, type of carrier plate, sample capacity, type of detection, and type of system used). 

Chapter 6 features detailed profiles of the prominent players offering biosensors for drug discovery applications. Each profile features a brief overview of the company, details related to its product portfolio, recent developments and an informed future outlook.

Chapter 7 provides an elaborative brand positioning analysis of the leading industry players (shortlisted on the basis of year of establishment, number of biosensors developed and company size), highlighting the current perceptions regarding their proprietary brands across biosensors in drug discovery.

Chapter 8 provides details on the various investments that have been made into companies developing biosensors for drug discovery applications, including seed financing, venture capital financing, capital raised from IPOs and subsequent offerings, grants and debt financing. The investment instances have been analyzed based on various relevant parameters, such as year of investment, amount invested, type of funding, most active players (in terms of number of funding instances and amount) and type of investor.

Chapter 9 features a detailed review of peer-reviewed, scientific articles related to research on biosensors in drug discovery, on the basis of several relevant parameters, such as year of publication, type of publication, emerging focus areas, most active publisher, most active affiliated institutes and geography. The chapter also highlights the top journals (in terms of number of articles published and impact factor).

Chapter 10 features an analysis of the global events attended by the participants, based on several parameters, such as year of event, type of event platform, location of event, emerging focus areas, active organizers (in terms of number of events), active industry and non-industry participants, designation of participants, affiliated organizations of participant. The chapter also highlights the geographical mapping of upcoming events.

Chapter 11 provides an insightful analysis of the patents filed / granted for biosensors used for drug discovery during the period between 2018 and 2022 taking into consideration several relevant parameters, such as type of patent, publication year, application year, geographical location, Cooperative Patent Classification (CPC) symbols, emerging focus area, leading industry and non-industry players (on the basis of number of patents) and individual patent assignees (in terms of size of intellectual property portfolio), patent characteristics and age of patents. The chapter also includes an insightful valuation analysis.

Chapter 12 presents an insightful market forecast analysis, highlighting the likely growth of the biosensors in drug discovery market till the year 2035. In order to provide details on the future opportunity, our projections have been segmented on the basis of [A] type of biosensor (optical, electrochemical, thermal and others), [B] type of end user (academic and research institutes, and industry players) and [C] key geographies (North America, Europe, Asia Pacific, Middle East and North Africa, Latin America and Rest of the world). 

Chapter 13 summarizes the overall report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.

Chapter 14 provides the transcripts of interviews conducted with key stakeholders of this market. In this chapter, we have presented the details of our conversation with Bill Rader (Chief Executive Officer, Efferent Labs), Anne Marie Quinn (Chief Executive Officer, Montana Molecular), and Laurent Sabbagh (Associate Director R&D and Head of Biology, Domain Therapeutics). 

Chapter 15 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 16 is an appendix, which contains the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. An Overview of Biosensors
3.3. Components of Biosensors
3.4. Types of Biosensors
3.5. Applications of Biosensors in Drug Discovery
3.6. Challenges Associated with Use of Biosensors in Drug Discovery
3.7. Concluding Remarks

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Biosensors in Drug Discovery: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Most Active Players: Analysis by Number of Biosensors Developed
4.2.5. Analysis by Type of Biosensor
4.2.6. Analysis by Type of Bioreceptor Used
4.2.7. Analysis by Type of Biosensor and Type of Bioreceptor Used
4.2.8. Analysis by Drug Discovery Step(s) Supported
4.2.9. Analysis by Other Applications Supported
4.2.10. Analysis by Type of Analyte
4.2.11. Analysis by Carrier Plate Format
4.2.12. Analysis by Type of Biosensor and Carrier Plate Format
4.2.13. Analysis by Sample Capacity
4.2.14. Analysis by Sample Volume
4.2.15. Analysis by Type of Detection Method Employed
4.2.16. Analysis by Type of System

5. PRODUCT COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.3. Product Competitiveness Analysis: Biosensors in Drug Discovery

6. COMPANY PROFILES: BIOSENSORS DEVELOPERS FOR DRUG DISCOVERY APPLICATIONS
6.1. Chapter Overview
6.2. Agilent Technologies
6.2.1. Company Overview
6.2.2. Product Portfolio
6.2.3. Recent Developments and Future Outlook

6.3. Axion Biosystems
6.3.1. Company Overview
6.3.2. Product Portfolio
6.3.3. Recent Developments and Future Outlook

6.4. BioNavigations
6.4.1. Company Overview
6.4.2. Product Portfolio
6.4.3. Recent Developments and Future Outlook

6.5. Creoptix
6.5.1. Company Overview
6.5.2. Product Portfolio
6.5.3. Recent Developments and Future Outlook

6.6. Cytiva
6.6.1. Company Overview
6.6.2. Product Portfolio
6.6.3. Recent Developments and Future Outlook

6.7. Dynamic Biosensors
6.7.1. Company Overview
6.7.2. Product Portfolio
6.7.3. Recent Developments and Future Outlook

6.8. Malvern Panalytical
6.8.1. Company Overview
6.8.2. Product Portfolio
6.8.3. Recent Developments and Future Outlook

6.9. Microvacuum
6.9.1. Company Overview
6.9.2. Product Portfolio
6.9.3. Recent Developments and Future Outlook

6.10. Sartorius
6.10.1. Company Overview
6.10.2. Product Portfolio
6.10.3. Recent Developments and Future Outlook

6.11. Tempo Bioscience
6.11.1. Company Overview
6.11.2. Product Portfolio
6.11.3. Recent Developments and Future Outlook

7. BRAND POSITIONING ANALYSIS
7.1. Chapter Overview
7.2 Key Parameters
7.3. Methodology
7.4. Biosensor Developers for Drug Discovery Applications
7.4.1. Brand Positioning Matrix: Agilent Technologies
7.4.2. Brand Positioning Matrix: Cytiva
7.4.3. Brand Positioning Matrix: Sartorius
7.4.4. Brand Positioning Matrix: Malvern Panalytical

8. FUNDING AND INVESTMENT ANALYSIS
8.1. Chapter Overview
8.2. Types of Funding
8.3. Biosensors in Drug Discovery: Funding and Investments
8.3.1. Analysis of Funding Instances by Year
8.3.2. Analysis of Amount Invested by Year
8.3.3. Analysis of Funding Instances by Type of Funding
8.3.4. Analysis of Amount Invested by Type of Funding
8.3.5. Analysis of Funding Instances by Type of Biosensor
8.3.6. Most Active Players: Analysis by Number of Funding Instances
8.3.7. Most Active Players: Analysis by Amount Invested
8.3.8. Most Active Investors: Analysis by Number of Funding Instances
8.3.9. Analysis of Amount Invested by Geography
8.3.9.1. Analysis by Region
8.3.9.2. Analysis by Country

9. PUBLICATION ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Biosensors in Drug Discovery: Publication Analysis
9.3.1. Analysis by Year of Publication
9.3.2. Analysis by Type of Publication
9.3.3. Most Popular Journals: Analysis by Number of Publications
9.3.4. Most Popular Journals: Analysis by Impact Factor
9.3.5. Analysis by Most Popular Keywords
9.3.6. Most Active Publisher: Analysis by Number of Publications
9.3.7. Most Active Affiliated Institutes: Analysis by Number of Publications
9.3.8. Analysis by Geography

10. GLOBAL EVENT ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. List of Global Events Related to Biosensors in Drug Discovery
10.3.1. Analysis by Year of Event
10.3.2. Analysis by Event Platform
10.3.3. Analysis by Type of Event
10.3.4. Analysis by Location of Event
10.3.5. Analysis by Evolutionary Trends in Event Agendas / Key Focus Areas
10.3.6. Most Active Organizers: Analysis by Number of Events
10.3.7. Analysis by Designation of Participants
10.3.8. Analysis by Affiliated Department of Participants
10.3.9. Analysis by Geography of Upcoming Events

11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Biosensors in Drug Discovery: Patent Analysis
11.3.1. Analysis by Publication Year
11.3.2. Analysis by Geography
11.3.3. Analysis by CPC Symbols
11.3.4. Analysis by Emerging Focus Areas
11.3.5. Analysis by Patent Age
11.3.6. Analysis by Type of Applicant
11.3.7. Leading Industry Players: Analysis by Number of Patents
11.3.8. Leading Non-Industry Players: Analysis by Number of Patents
11.3.9. Leading Individual Assignees: Analysis by Number of Patents

11.4. Biosensors in Drug Discovery: Patent Valuation
11.5. Leading Patents: Analysis by Number of Citations

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Biosensors in Drug Discovery Market, 2022-2035

12.3.1. Biosensors in Drug Discovery Market: Distribution by Type of Biosensor, 2022 and 2035
12.3.1.1. Optical Biosensors in Drug Discovery Market, 2022-2035
12.3.1.2. Electrochemical Biosensors in Drug Discovery Market, 2022-2035
12.3.1.3. Thermal Biosensors in Drug Discovery Market, 2022-2035
12.3.1.4. Other Biosensors in Drug Discovery Market, 2022-2035

12.3.2. Biosensor in Drug Discovery Market: Distribution by Type of End User, 2022 and 2035
12.3.2.1. Biosensor in Drug Discovery Market for Academic and Research Institutes, 2022-2035
12.3.2.2. Biosensor in Drug Discovery Market for Industry Players, 2022-2035

12.3.3. Biosensor in Drug Discovery Market: Distribution by Region, 2022 and 2035
12.3.3.1. Biosensor in Drug Discovery Market in North America, 2022-2035
13.3.3.2. Biosensor in Drug Discovery Market in Europe, 2022-2035
12.3.3.3. Biosensor in Drug Discovery Market in Asia Pacific, 2022-2035
12.3.3.4. Biosensor in Drug Discovery Market in Latin America, 2022-2035
12.3.3.5. Biosensor in Drug Discovery Market in Middle East and North Africa, 2022-2035
12.3.3.6. Biosensor in Drug Discovery Market in Rest of the World, 2022-2035

13. CONCLUDING REMARKS

14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Efferent Labs
14.2.1. Company Snapshot
14.2.2. Interview Transcript: Bill Rader (Chief Executive Officer)

14.3. Montana Molecular
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Anne Marie Quinn (Chief Executive Officer)

14.4. Domain Therapeutics
14.4.1. Company Snapshot
14.4.2. Interview Transcript: Laurent Sabbagh (Associate Director R&D, Head of Biology)

15. APPENDIX 1: TABULATED DATA

16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Funding and Investments
Figure 2.3 Executive Summary: Publication Analysis
Figure 2.4 Executive Summary: Global Event Analysis
Figure 2.5 Executive Summary: Patent Analysis
Figure 2.6 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Components of Biosensors
Figure 3.2 Electrochemical Biosensor
Figure 3.3 Thermal Biosensor
Figure 3.4 Optical Biosensor
Figure 3.5 Piezo-electric Biosensor
Figure 3.4 Resonant Biosensor
Figure 4.1 Biosensor Developers for Drug Discovery Applications: Distribution by Year of Establishment
Figure 4.2 Biosensor Developers for Drug Discovery Applications: Distribution by Company Size
Figure 4.3 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters (Region-wise)
Figure 4.4 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters (Country-wise)
Figure 4.5 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters and Company Size
Figure 4.6 Most Active Players: Distribution by Number of Biosensors Developed
Figure 4.7 Biosensors in Drug Discovery: Distribution by Type of Biosensor
Figure 4.8 Biosensors in Drug Discovery: Distribution by Type of Bioreceptor Used
Figure 4.9 Biosensors in Drug Discovery: Distribution by Type of Biosensor and Type of Bioreceptor Used
Figure 4.10 Biosensors in Drug Discovery: Distribution by Drug Discovery Step(s) Supported
Figure 4.11 Biosensors in Drug Discovery: Distribution by Other Applications Supported
Figure 4.12 Biosensors in Drug Discovery: Distribution by Type of Analyte
Figure 4.13 Biosensors in Drug Discovery: Distribution by Carrier Plate Format
Figure 4.14 Biosensors in Drug Discovery: Distribution by Type of Biosensor and Carrier Plate Format
Figure 4.15 Biosensors in Drug Discovery: Distribution by Sample Capacity
Figure 4.16 Biosensors in Drug Discovery: Distribution by Sample Volume
Figure 4.17 Biosensors in Drug Discovery: Distribution by Type of Detection Method Employed
Figure 4.18 Biosensors in Drug Discovery: Distribution by Type of System
Figure 5.1 Product Competitiveness Analysis: Dot Plot Analysis
Figure 5.2 Product Competitiveness Analysis: Biosensors in Drug Discovery
Figure 7.1 Biosensor Developers for Drug Discovery Applications: Brand Positioning Matrix
Figure 7.2 Brand Positioning Matrix: Agilent Technologies
Figure 7.3 Brand Positioning Matrix: Cytiva
Figure 7.4 Brand Positioning Matrix: Sartorius
Figure 7.5 Brand Positioning Matrix: Malvern Panalytical
Figure 8.1 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, 2018-2022
Figure 8.2 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, 2018-2022 (USD Million)
Figure 8.3 Funding and Investment Analysis: Distribution of Funding Instances by Type of Funding
Figure 8.4 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding (USD Million)
Figure 8.5 Funding and Investment Analysis: Distribution of Funding Instances by Type of Biosensor
Figure 8.6 Most Active Players: Distribution by Number of Funding Instances
Figure 8.7 Most Active Players: Distribution by Amount Invested (USD Million)
Figure 8.8 Most Active Investors: Distribution by Number of Funding Instances
Figure 8.9 Funding and Investment Analysis: Distribution of Amount Invested by Region (USD Million)
Figure 8.10 Funding and Investment Analysis: Distribution of Amount Invested by Country (USD Million)
Figure 9.1 Publication Analysis: Distribution by Year of Publication
Figure 9.2 Publication Analysis: Distribution by Type of Publication
Figure 9.3 Most Popular Journals: Distribution by Number of Publications
Figure 9.4 Most Popular Journals: Distribution by Impact Factor
Figure 9.5 Publication Analysis: Most Popular Keywords
Figure 9.6 Most Active Publisher: Distribution by Number of Publications
Figure 9.7 Most Active Affiliated Institutes: Distribution by Number of Publications
Figure 9.8 Publication Analysis: Distribution by Geography
Figure 10.1 Global Event Analysis: Cumulative Quarterly Trend
Figure 10.2 Global Event Analysis: Distribution by Event Platform
Figure 10.3 Global Event Analysis: Distribution by Type of Event
Figure 10.4 Global Event Analysis: Distribution by Location of Event
Figure 10.5 Global Event Analysis: Distribution by Evolutionary Trends in Event Agenda / Key Focus Area
Figure 10.6 Most Active Organizers: Distribution by Number of Events
Figure 10.7 Global Event Analysis: Distribution by Designation of Participants
Figure 10.8 Global Event Analysis: Distribution by Affiliated Department of Participants
Figure 10.9 Global Event Analysis: Geography of Upcoming Events
Figure 11.1 Patent Analysis: Distribution by Type of Patent
Figure 11.2 Patent Analysis: Distribution by Patent Publication Year
Figure 11.3 Patent Analysis: Distribution by Geography
Figure 11.4 Patent Analysis: Distribution by CPC Symbols
Figure 11.5 Patent Analysis: Emerging Focus Areas
Figure 11.6 Patent Analysis: Distribution by Patents Age
Figure 11.7 Patent Analysis: Distribution by Type of Applicant
Figure 11.8 Leading Industry Players: Distribution by Number of Patents
Figure 11.9 Leading Non-Industry Players: Distribution by Number of Patents
Figure 11.10 Leading Individual Assignees: Distribution by Number of Patents
Figure 11.11 Biosensors in Drug Discovery: Patent Valuation Analysis
Figure 12.1 Global Biosensors in Drug Discovery Market, 2022-2035 (USD Billion)
Figure 12.2 Biosensors in Drug Discovery Market: Likely Growth Scenarios
Figure 12.3 Biosensors in Drug Discovery Market: Distribution by Type of Biosensor, 2022 and 2035 (USD Billion)
Figure 12.4 Optical Biosensors in Drug Discovery Market, 2022-2035 (USD Billion)
Figure 12.5 Electrochemical Biosensors in Drug Discovery Market, 2022-2035 (USD Billion)
Figure 12.6 Thermal Biosensors in Drug Discovery Market, 2022-2035 (USD Billion)
Figure 12.7 Other Biosensors in Drug Discovery Market, 2022-2035 (USD Billion)
Figure 12.8 Biosensors in Drug Discovery Market: Distribution by Type of End User, 2022 and 2035
Figure 12.9 Biosensors in Drug Discovery Market for Academic and Research Institutes, 2022-2035 (USD Billion)
Figure 12.10 Biosensors in Drug Discovery Market for Industry Players, 2022-2035 (USD Billion)
Figure 12.11 Biosensors in Drug Discovery Market: Distribution by Region, 2022 and 2035
Figure 12.12 Biosensors in Drug Discovery Market in North America, 2022-2035 (USD Billion)
Figure 12.13 Biosensors in Drug Discovery Market in Europe, 2022-2035 (USD Billion)
Figure 12.14 Biosensors in Drug Discovery Market in Asia Pacific, 2022-2035 (USD Billion)
Figure 12.15 Biosensors in Drug Discovery Market in Latin America, 2022-2035 (USD Billion)
Figure 12.16 Biosensors in Drug Discovery Market in Middle East and North Africa, 2022-2035 (USD Billion)
Figure 12.17 Biosensors in Drug Discovery Market in Rest of the World, 2022-2035 (USD Billion)
Figure 13.1 Concluding Remarks: Market Landscape
Figure 13.2 Concluding Remarks: Funding and Investments Analysis
Figure 13.3 Concluding Remarks: Publication Analysis
Figure 13.4 Concluding Remarks: Global Event Analysis
Figure 13.5 Concluding Remarks: Patent Analysis
Figure 13.6 Concluding Remarks: Market Forecast and Opportunity Analysis

List Of Tables

Table 4.1 Biosensors in Drug Discovery: List of Companies
Table 4.2 Biosensors in Drug Discovery: Information on Type of Biosensor, Bioreceptor used, Drug Discovery Step(s) and Other Applications Supported
Table 4.3 Biosensors in Drug Discovery: Information on Type of Analyte
Table 4.4 Biosensors in Drug Discovery: Information on Carrier Plate Format, Sample Capacity, Sample Volume, Type of Detection Method Employed and Type of System
Table 6.1 Leading Biosensor Developers
Table 6.2 Agilent Technologies: Company Overview
Table 6.3 Agilent Technologies: Product Portfolio
Table 6.4 Agilent Technologies: Recent Developments and Future Outlook
Table 6.5 Axion Biosystems: Company Overview
Table 6.6 Axion Biosystems: Product Portfolio
Table 6.7 BioNavigations: Company Overview
Table 6.8 BioNavigations: Product Portfolio
Table 6.9 Creoptix: Company Overview
Table 6.10 Creoptix: Product Portfolio
Table 6.11 Creoptix: Recent Developments and Future Outlook
Table 6.12 Cytiva: Company Overview
Table 6.13 Cytiva: Product Portfolio
Table 6.14 Cytiva: Recent Developments and Future Outlook
Table 6.15 Dynamic Biosensors: Company Overview
Table 6.16 Dynamic Biosensors: Product Portfolio
Table 6.17 Dynamic Biosensors: Recent Developments and Future Outlook
Table 6.18 Malvern Panalytical: Company Overview
Table 6.19 Malvern Panalytical: Product Portfolio
Table 6.20 Malvern Panalytical: Recent Developments and Future Outlook
Table 6.21 Microvacuum: Company Overview
Table 6.22 Microvacuum: Product Portfolio
Table 6.23 Sartorius: Company Overview
Table 6.24 Sartorius: Product Portfolio
Table 6.25 Sartorius: Recent Developments and Future Outlook
Table 6.26 Tempo Bioscience: Company Overview
Table 6.27 Tempo Bioscience: Product Portfolio
Table 8.1 Biosensors in Drug Discovery: List of Funding and Investments, 2018-2022
Table 9.1 Biosensors in Drug Discovery: List of Recent Publications, 2018-2022
Table 10.1 Biosensors in Drug Discovery: List of Global Events, 2021-H2 2023
Table 11.1 Patent Analysis: Prominent CPC Symbols
Table 11.2 Patent Analysis: Most Popular CPC Symbols
Table 11.3 Patent Analysis: List of Top CPC Symbols
Table 11.4 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 11.5 Patent Portfolio: List of Leading Patents (in terms of Highest Relative Valuation)
Table 11.6 Patent Portfolio: List of Leading Patents (in terms of Number of Citations)
Table 14.1 Efferent Labs: Company Snapshot
Table 14.2 Montana Molecular: Company Snapshot
Table 14.2 Domain Therapeutics: Company Snapshot
Table 15.1 Biosensor Developers for Drug Discovery Applications: Distribution by Year of Establishment
Table 15.2 Biosensor Developers for Drug Discovery Applications: Distribution by Company Size
Table 15.3 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters (Region-wise)
Table 15.4 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters (Country-wise)
Table 15.5 Biosensor Developers for Drug Discovery Applications: Distribution by Location of Headquarters and Company Size
Table 15.6 Most Active Players: Distribution by Number of Biosensors Developed
Table 15.7 Biosensors in Drug Discovery: Distribution by Type of Biosensor
Table 15.8 Biosensors in Drug Discovery: Distribution by Type of Bioreceptor Used
Table 15.9 Biosensors in Drug Discovery: Distribution by Type of Biosensor and Type of Bioreceptor Used
Table 15.10 Biosensors in Drug Discovery: Distribution by Drug Discovery Step(s) Supported
Table 15.11 Biosensors in Drug Discovery: Distribution by Other Applications Supported
Table 15.12 Biosensors in Drug Discovery: Distribution by Type of Analyte
Table 15.13 Biosensors in Drug Discovery: Distribution by Carrier Plate Format
Table 15.14 Biosensors in Drug Discovery: Distribution by Type of Biosensor and Carrier Plate Format
Table 15.15 Biosensors in Drug Discovery: Distribution by Sample Capacity
Table 15.16 Biosensors in Drug Discovery: Distribution by Sample Volume
Table 15.17 Biosensors in Drug Discovery: Distribution by Type of Detection Method Employed
Table 15.18 Biosensors in Drug Discovery: Distribution by Type of System
Table 15.19 Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances, 2018-2022
Table 15.20 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, 2018-2022 (USD Million)
Table 15.21 Funding and Investment Analysis: Distribution of Funding Instances by Type of Funding
Table 15.22 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding (USD Million)
Table 15.23 Funding and Investment Analysis: Distribution of Funding Instances by Type of Biosensor
Table 15.24 Most Active Players: Distribution by Number of Funding Instances
Table 15.25 Most Active Players: Distribution by Amount Invested (USD Million)
Table 15.26 Most Active Investors: Distribution by Number of Funding Instances
Table 15.27 Funding and Investment Analysis: Distribution of Amount Invested by Region (USD Million)
Table 15.28 Funding and Investment Analysis: Distribution of Amount Invested by Country (USD Million)
Table 15.29 Publication Analysis: Distribution by Year of Publication
Table 15.30 Publication Analysis: Distribution by Type of Publication
Table 15.31 Most Popular Journals: Distribution by Number of Publications
Table 15.32 Most Popular Journals: Distribution by Impact Factor
Table 15.33 Publication Analysis: Most Popular Keywords
Table 15.34 Most Active Publisher: Distribution by Number of Publications
Table 15.35 Most Active Affiliated Institutes: Distribution by Number of Publications
Table 15.36 Publication Analysis: Distribution by Geography
Table 15.37 Global Event Analysis: Cumulative Quarterly Trend
Table 15.38 Global Event Analysis: Distribution by Event Platform
Table 15.39 Global Event Analysis: Distribution by Type of Event
Table 15.40 Global Event Analysis: Distribution by Location of Event
Table 15.41 Most Active Organizers: Distribution by Number of Events
Table 15.42 Global Event Analysis: Distribution by Designation of Participants
Table 15.43 Global Event Analysis: Distribution by Affiliated Department of Participants
Table 15.44 Global Event Analysis: Geographical Mapping of Upcoming Events
Table 15.45 Patent Analysis: Distribution by Type of Patent
Table 15.46 Patent Analysis: Distribution by Patent Publication Year
Table 15.47 Patent Analysis: Distribution by Geography
Table 15.48 Patent Analysis: Distribution by CPC Symbols
Table 15.49 Patent Analysis: Distribution by Patents Age
Table 15.50 Patent Analysis: Distribution by Type of Applicant
Table 15.51 Leading Industry Players: Distribution by Number of Patents
Table 15.52 Leading Non-Industry Players: Distribution by Number of Patents
Table 15.53 Leading Individual Assignees: Distribution by Number of Patents
Table 15.54 Biosensors in Drug Discovery: Patent Valuation Analysis
Table 15.55 Global Biosensors in Drug Discovery Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.56 Biosensors in Drug Discovery Market: Distribution by Type of Biosensor, 2022 and 2035
Table 15.57 Optical Biosensors in Drug Discovery Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.58 Electrochemical Biosensors in Drug Discovery Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.59 Thermal Biosensors in Drug Discovery Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.60 Other Biosensors in Drug Discovery Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.61 Biosensors in Drug Discovery Market: Distribution by Type of End User, 2022 and 2035
Table 15.62 Biosensors in Drug Discovery Market for Academic and Research Institutions, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.63 Biosensors in Drug Discovery Market for Industry Players, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.64 Biosensors in Drug Discovery Market: Distribution by Region, 2022 and 2035
Table 15.65 Biosensors in Drug Discovery Market in North America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.66 Biosensors in Drug Discovery Market in Europe, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.67 Biosensors in Drug Discovery Market in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.68 Biosensors in Drug Discovery Market in Latin America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.69 Biosensors in Drug Discovery Market in Middle East and North Africa, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.70 Biosensors in Drug Discovery Market in Rest of the World, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)

List Of Companies

The following companies and organizations have been mentioned in the report:

1. 3E Bioventures Capital
2. ACEA Biosciences
3. Agency for Science, Technology and Research (A*STAR) 
4. Agilent Technologies
5. Agilome
6. Alexandria Venture Investments
7. Applied BioPhysics
8. Aromyx
9. ARTIS Ventures
10. Attana
11. Axion BioSystems
12. Ballast Point Ventures
13. Beactica Therapeutics
14. BioLoomics
15. BioNavigations
16. BiOptix Analytical 
17. Biosens Labs
18. Biosensing Instrument
19. Boston University
20. Bruker
21. Cardea Bio
22. Carterra
23. Catalan Institute of Nanoscience and Nanotechnology (ICN2)
24. Chinese Academy of Sciences
25. Comerica Bank's Technology & Life Sciences Division
26. Columbia University
27. Creoptix (Acquired by Malvern Panalytical)
28. Cytiva
29. Delix therapeutics
30. Domain Therapeutics
31. Dresden University of Technology (TUD)
32. Dynamic Biosensors
33. Swiss Federal Institute of Technology Lausanne
34. Efferent Labs
35. Eindhoven University of Technology
36. Falcon III Ventures
37. Garage Capital
38. Gator Bio
39. GE Healthcare
40. Genapsys
41. Harvard College
42. Helmholtz-Zentrum Dresden-Rossendorf
43. HORIBA
44. High-Tech Gründerfonds
45. IBIS Technologies
46. IBM
47. Indian Institute of Technology, Madras
48. InterAx Biotech
49. International Iberian Nanotechnology Laboratory (INL)
50. Interuniversity Microelectronics Centre (IMEC)
51. Invitrometrix
52. Karlsruhe Institute of Technology
53. Laurier Startup Fund 
54. Lifespan Investments
55. lino Biotech
56. MagArray
57. Malvern Panalytical
58. MaRS Investment Accelerator Fund
59. MicroVacuum
60. Molecular Devices
61. Monash University
62. Montana Molecular
63. National Center for Scientific Research (CNRS)
64. National Institute on Drug Abuse
65. National Nanotechnology Coordination Office (NNCO)
66. Nicoya Lifesciences
67. Ningbo University
68. NRI R&D Patent Licensing
69. OMX Ventures
70. Osaka University
71. Photon Fund
72. Photonic Pharma
73. Plexense
74. Provigate
75. RA Capital Management
76. Roche
77. Roche Venture Fund
78. Roswell Biotechnologies
79. Sapidyne Instruments
80. Sartorius
81. Seoul National University
82. Serra Ventures
83. Seventure Partners
84. Sorbonne Université
85. Stanford University
86. Swisscanto
87. Table Mountain Capital
88. Taihill Venture
89. Taiwan Semiconductor Manufacturing (TMSC)
90. Telegraph Hill Partners
91. Tempo Bioscience
92. National Institutes of Health
93. Tsingyuan Ventures
94. US Department of Homeland Security
95. Umm Al-Qura University
96. University of La Sabana
97. University of Auckland
98. University of Bologna
99. University of California
100. University of Chicago
101. Johns Hopkins University
102. University of Malaya
103. University of Medicine and Pharmacy Craiova
104. University of Minnesota
105. University of Montreal
106. University of Oxford
107. University of Porto
108. University of Strathclyde
109. Vanderbilt University
110. University of Waterloo Student Venture Fund
111. Warsaw University of Technology
112. Waters Corporation
113. Whitecap Venture Partners